CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÇãÁö¿µ
  • ±âÁõÁ¦´ëÇ÷ÀºÇàÀå
    Áø´Ü°Ë»çÀÇÇаúÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : Áø´ÜÇ÷¾×ÇÐ, ¼öÇ÷ÀÇÇÐ, Á¶Á÷ÀûÇÕ¼º, ºÐÀÚÀ¯Àü
  • Á÷ À§: ±³¼ö(±âÁõÁ¦´ëÇ÷ÀºÇàÀå,Áø´Ü°Ë»çÀÇÇаúÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­:
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
20 (±¹³»)±âŸ CTX-M-12, PER-1 ¹× OXA-30 ¥â-Lactamase »ý¼º Klebsiella pneumoniaeÀÇ ÃâÇö
19 (±¹³»)±âŸ ¼ºÀÎ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´¿¡¼­ Àú°­µµ µ¿Á¾ Á¦´ëÇ÷ÀÌ½Ä 4¿¹
18 (±¹¿Ü)SCI A novel ceftazidime-hydrolysing extended-spectrum ¥â-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop
17 (±¹³»)KCIÈĺ¸ Multilocus Sequence Typing of Clonal Changes of Methicillin-resistant Staphylococcus aureus Isolated from Intensive Care Unit Patients: 1996 versus 2004
16 (±¹³»)±âŸ ±ÕÇ÷Áõ ¹× ¿ä·Î°¨¿°¿¡¼­ ºÐ¸®µÈ À屸±ÕÀÇ Ç×±ÕÁ¦ ³»¼º ¹× º´µ¶¼º ÀÎÀÚ ±Ô¸í
15 (±¹³»)KCI ȸÀå ¸»´ÜºÎ¿¡ ±Ë¾çÀ» µ¿¹ÝÇÑ Ç÷±¸Å½½ÄÁõÈıº 1¿¹
14 (±¹³»)KCI CTX-M-12¿Í »õ·Î¿î CTX-MÇü Extended-Spectrum -Lactamase »ý¼º Klebsiella pneumoniaeÀÇ ÃâÇö
13 (±¹³»)KCI TTP Áø´ÜÀ» À§ÇÑFluorescence-quenching substrate¸¦ ÀÌ¿ëÇÑ »õ·Î¿îADAMTS-13 È°¼ºµµ ÃøÁ¤¹ýÀÇ À¯¿ë¼º
12 (±¹¿Ü)SCI Molecular characterization of vancomycin-resistant enterococci from clinical and surveillance specimens
11 (±¹³»)KCI ¹Úµ¿¼ö, ¿Àµµ¿¬, °­¸í¼­, ¾ÈÈñÁ¤, À̼±ÁÖ, ±è³²±Ù: ÀüÀ̼º ½Å¼¼Æ÷¾ÏÀÇ º¸Á¶ ¸é¿ªÄ¡·á·Î½á ÀÚ°¡Á¾¾ç¹é½ÅÀÇ Àû¿ë
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729